|
|
|
|
LEADER |
01258cam a22003497a 4500 |
008 |
100225s2009 gw a b 001 0 eng d |
010 |
|
|
|a 2010286614
|
015 |
|
|
|a GBA948256
|2 bnb
|
016 |
7 |
|
|a 101512727
|2 DNLM
|
016 |
7 |
|
|a 015182030
|2 Uk
|
020 |
|
|
|a 9783527322053 (alk. paper)
|
020 |
|
|
|a 3527322051 (alk. paper)
|
035 |
|
|
|a (OCoLC)ocn321017981
|
042 |
|
|
|a ukblcatcopy
|a nlmcopyc
|a lccopycat
|
060 |
0 |
0 |
|a 2009 I-009
|
060 |
1 |
0 |
|a QU 68
|b P42425 2009
|
082 |
0 |
4 |
|a 615.19
|2 22
|
245 |
0 |
0 |
|a Peptides as drugs :
|b discovery and development /
|c edited by Bernd Groner.
|
260 |
|
|
|a Weinheim :
|b Wiley-VCH,
|c c2009.
|
300 |
|
|
|a xv, 226 p. :
|b ill. ;
|c 25 cm.
|
504 |
|
|
|a Includes bibliographical references and index.
|
650 |
|
0 |
|a Peptide drugs.
|
650 |
|
0 |
|a Drugs
|x Design.
|
650 |
1 |
2 |
|a Peptides
|x physiology.
|
650 |
2 |
2 |
|a Drug Discovery.
|
650 |
2 |
2 |
|a HIV Infections
|x drug therapy.
|
700 |
1 |
|
|a Groner, B.
|
942 |
|
|
|c BK
|
906 |
|
|
|a 7
|b cbc
|c copycat
|d 2
|e ncip
|f 20
|g y-gencatlg
|
955 |
|
|
|b xh14 2010-02-25 z-processor to xh00
|a xh00 2010-02-25 to USPL/STM
|i xh04 2010-08-30 to CALM
|
999 |
|
|
|c 96236
|d 96236
|
952 |
|
|
|0 0
|1 0
|4 0
|6 615_190000000000000_PEP
|7 0
|9 96045
|a UL
|b UL
|c REF
|d 2011-11-25
|g 0.00
|l 0
|o 615.19 PEP
|p 86391
|r 2012-10-28
|v 12048.00
|y TXT
|